Astrazeneca PLC Price Today
Astrazeneca PLC
AZN
Healthcare
$209.90B
💰
Market Cap
35.6
💸
Price to Earnings
$1.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
17 |
Strong Buy |
9 |
Hold |
7 |
Sell |
2 |
Strong Sell |
0 |
AZN Price Forecast Target
67.7 👉 91.7 +35%
AZN EPS Forecast
1.9 👉 4.4 +131%
Financials
Profit Margin
13 %
Revenue Growth
7.3 %
Dividend
$ 1.45
Held Percent
0.0% - Insiders
16.8% - Institutions
83.2% - Public
Major Fund Holders
-
💰 Price (T.Rowe) Associates Inc $3.5B
-
💰 Wellington Management Group, LLP $3.3B
-
💰 Primecap Management Company $2.9B
-
💰 Capital International Investors $2.4B
-
💰 FMR, LLC $1.4B
Stock Ideas
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…📮FAQ
Some Frequently Asked Questions.
The Astrazeneca PLC industry is Drug Manufacturers - General
The Astrazeneca PLC sector is Healthcare
The Astrazeneca PLC forecasted predicted Price to Earnings PE ratio is 15.5
The Astrazeneca PLC Price to Earnings PE ratio is 35.6
The Market Capitalization of Astrazeneca PLC is $209.90B
There are total of 1544582041 float shares with 16.8% held by Institutions and 0.0% held by insiders
The MAstrazeneca PLC forecasted Earnings per Share EPS is $4.4
The Astrazeneca PLC Earnings per Share EPS is 1.9
The Astrazeneca PLC company has $0 gross profits with 13 profit margins
The Astrazeneca PLC Earnings Growth is 0.059% with 0.065% quarterly earnings growth
The Astrazeneca PLC Revenue is $45810999296 with 0.073 revenue growth
The price target for Astrazeneca PLC stock is $91.7 for the high target and $70.0 for the low target
The consensus analyst recommendations for Astrazeneca PLC is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Astrazeneca PLC is Buy, with the following breakdown:
- Buy: 17
- Strong Buy: 9
- Hold: 7
- Sell: 2
- Strong Sell: 0
The Beta of Astrazeneca PLC is 0.2
The dividend of Astrazeneca PLC is $1.45
The dividend yield of Astrazeneca PLC is 0.0212%
The biggest institutional and mutual fund holders of Astrazeneca PLC stock are
- Price (T.Rowe) Associates Inc
- Wellington Management Group, LLP
- Primecap Management Company
- Capital International Investors
The Astrazeneca PLC ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0